Delivery Order SPE2DB20D2104-SPE2DB25FMYUC
- Not listed
- The Defense Logistics Agency awarded a $1,604.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Fycompa 0.5 mg/mL oral suspension in a 340 mL quantity, with a contract value of $2,903.46. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340 ml quantity, valued at $13,461.85 under a firm fixed price contract. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global...
- This is a $3,061.58 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FYCOMPA 0.5 MG/ML oral suspension, a prescription medication, with a period of performance through April 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Department...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 0.5 MG/ML Oral Suspension 340ML, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $4,333.54. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of May 1, 2025 and was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,524.73 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for this...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYUCDelivery Order
The Defense Logistics Agency awarded a $12,464.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340 ml) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's DLA prime contract enables supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. FYCOMPA (perampanel) is a neurological medication used in seizure management, consistent with AmerisourceBergen's extensive portfolio of therapeutic medications supplied through competitively awarded federal contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 8/25/25 |